Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents.

Cells - 23 Nov 2019

Bojko Agnieszka, Czarnecka-Herok Joanna, Charzynska Agata, Dabrowski Michal, Sikora Ewa

Abstract excerpt

It is acknowledged that cancer cells are able to undergo senescence in response to clinically used chemotherapeutics. Moreover, recent years have provided evidence that some drugs can selectively remove senescent cells. Therefore, it is essential to properly identify and characterize senescent cells, especially when it comes to cancer. Senescence was induced in various cancer cell lines (A549, SH-SY-5Y, HCT116,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular Senescence
Share to Cyclin-Dependent Kinase Inhibitor p21

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Doxorubicin

Share to Fluorouracil

Share to Irinotecan

Share to Methotrexate

Share to Oxaliplatin

Share to Paclitaxel

Source

Open in PubMed Open full text

Identifiers

PMID: 31771226
DOI: 10.3390/cells8121501
PMCID: PMC6952928

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents.PMID 31771226Read ↗

Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectivesSemantic proximity Read ↗

Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cellsSemantic proximity Read ↗

Therapy-Induced Senescence: An “Old” Friend Becomes the EnemySemantic proximity Read ↗

Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneitySemantic proximity Read ↗

Cellular Senescence in the Development and Treatment of CancerSemantic proximity Read ↗

Role of senescence induction in cancer treatmentSemantic proximity Read ↗

Senescence in neural cell lines: comparative insights from SH-SY5Y and ReNcell VMSemantic proximity Read ↗

Apoptosis-coupled senescence causes cancer cell senotherapySemantic proximity Read ↗

KRAS Inhibition Reverses Chemotherapy Resistance Promoted by Therapy-Induced Senescence-like in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Therapy-induced senescence in breast cancer: an overviewSemantic proximity Read ↗

Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLCSemantic proximity Read ↗

Therapy-Induced Senescence in CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.